-+ 0.00%
-+ 0.00%
-+ 0.00%

NEWAMSTERDAM PHARMA COMPANY N.V. - TOPLINE DATA FROM RUBENS PHASE 3 EXPECTED BY YEAR-END 2026

Reuters·08/05/2026 11:10:16

Please log in to view news